Evidence map›Paper›PMID 39544880›Full record

ArticleIJTLD open2024

Analysis of panel physician inquiries to U.S. TB Centers of Excellence, 2018-2022.

E Leithead, S Subramanian, K Pimenta, N D Goswami, A Patrawalla, A Lardizabal, C Haley, L Chen, L Armitige, B Seaworth and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

E LeitheadRutgers New Jersey Medical School, Newark, NJ, USA.
S SubramanianRutgers New Jersey Medical School, Newark, NJ, USA.
K PimentaSchool of Public Health, University of Memphis, Memphis, TN, USA.
N D GoswamiDivision of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
A PatrawallaRutgers Global Tuberculosis Institute, Newark, NJ, USA.
A LardizabalRutgers Global Tuberculosis Institute, Newark, NJ, USA.
C HaleyDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
L ChenUCSF Curry International Tuberculosis Center, San Francisco, CA, USA.
L ArmitigeHeartland National TB Center, San Antonio, TX, USA.
B SeaworthHeartland National TB Center, San Antonio, TX, USA.
B SylvesterDivision of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
R BhavarajuRutgers New Jersey Medical School, Newark, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApplicants seeking entry into the United States are examined overseas for TB by panel physicians and international immigration clinicians guided by Centers for Disease Control and Prevention (CDC) TB Technical Instructions. To support this effort, CDC-funded TB Centers of Excellence (COEs) provide web-based expert consultation, with documentation stored in a medical consultation database (MCD). MCD analysis can reveal inquiry trends among panel physicians worldwide.

methodsTB-related queries in the COE MCD from January 1, 2018, to December 31, 2022, were analyzed using a descriptive coding scheme developed through inductive analysis, allowing multiple themes per entry.

resultsA total of 215 queries from 126 patients in 28 countries were analyzed. Major themes included evaluating diagnostic criteria, tailoring treatment, and managing comorbidities or adverse reactions. Diagnostic questions (

conclusionThe MCD analysis identified topics where TB expertise was provided in overseas medical evaluation. These topics highlight opportunities for targeted panel physician education to improve the health of individual applicants and advance U.S. TB elimination efforts.

Indexed as

guidanceimmigrationmedical consultationpanel physiciantuberculosis

Identifiers

PMID39544880
PMCPMC11558790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.